Article
Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice
13 Jun 2018
Abstract excerpt
Diminished growth factor signaling improves longevity in laboratory models, while a reduction in the somatotropic axis is favorably linked to human aging and longevity. Given the conserved role of this pathway on lifespan, therapeutic strategies, such as insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibodies (mAb), represent a promising translational tool to target human aging. To this end, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
